For example: Apple Inc, UTIL, Aluminum
NuVasive Inc
NASDAQ:NUVA
Market Close 11/27
47.60 USD +0.04 (+0.08%)
OPEN:
47.73
DAY RANGE:
47.16 - 48.15
PE:
57.96
PB:
3.05
PS:
2.70
WTD % 3.25
MTD % 7.13
QTD % -2.00
YTD % -38.45
* Updated at market close
NuVasive Inc (NASDAQ:NUVA) opened on Nov 27, 2020 at 47.73 USD and went marginally up by 0.08%. The intraday price range was 47.16 - 48.15 USD and eventually ended the session at 47.60 USD. The stock trade volume was 124,600.00 shares. The company's 52-week range is 28.55 - 81.91 USD.
Trading Statistics (Market Close Nov 27, 2020)
Market Cap 2.44 B
Outstanding Stock 51.42 M
Dividend 0.00
Dividend Yield 0.00
EPS 1.01
YTD Change -38.45%
52 Week's Range 28.55 - 81.91
Key Ratio & Margins (Market Close Nov 27, 2020)
Price/Earning 57.96
Price/Book Value 3.05
Price/Sales 2.70
ROA -
ROE -
Debt/Equity 1.09
Company Self Description
NuVasive, Inc., a medical device company, develops and markets minimally-disruptive surgical products and procedurally integrated services for spine surgery. The company's products focus on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. It was founded in 1997 and is headquartered in San Diego, California, United States.
Business Information
NuVasive Inc
Sector Health Care
Industry Health Care Equipment & Supplies
Exchange NASDAQ
Top Competitors (Market Close Nov 27, 2020)
  NUVA LIVN CMD ITGR
Daily Change (%) 0.08 1.27 2.32 0.37
WTD (%) 3.25 9.20 6.45 3.99
MTD (%) 7.13 7.77 25.31 24.36
QTD (%) -2.00 20.00 36.44 23.18
YTD (%) -38.45 -28.08 -15.44 -9.62
52-Week Change (%) -34.43 -36.38 -23.12 -5.12
Stock Performance (Market Close Nov 27, 2020)
  NUVA LIVN CMD ITGR
Daily Change (%) 0.08 1.27 2.32 0.37
WTD (%) 3.25 9.20 6.45 3.99
MTD (%) 7.13 7.77 25.31 24.36
QTD (%) -2.00 20.00 36.44 23.18
YTD (%) -38.45 -28.08 -15.44 -9.62
52-Week Change (%) -34.43 -36.38 -23.12 -5.12
Key Fundamentals (Market Close Nov 27, 2020)
  NUVA LIVN CMD ITGR
Market Cap 2.44 B 2.64 B 2.53 B 2.39 B
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin 4.70% -23.90% 7.00% 15.70%
P/E Ratio 57.96 -13.30 45.66 13.96
Price to Sales Ratio 2.70 3.17 3.17 2.21
Price to Book Ratio 3.05 2.96 6.35 2.32
Enterprise Value to EBITDA 17.43 -25.27 25.27 9.16
ROA - -10.10% 6.30% 8.30%
ROE - -16.70% 10.00% 18.20%
Debt/Equity 1.09 0.70 0.58 1.19
Asset Turnover Ratio 0.65 0.42 0.90 0.53
Current Ratio 3.45 1.07 2.51 2.53
Dividend Yield 0.00 0 0.30% 0
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 1.10 B 1.03 B 962.13 M 811.11 M
Cost Of Revenue 311.16 M 268.44 M 240.11 M 194.48 M
Gross Profit 790.56 M 758.24 M 722.03 M 616.63 M
Selling General & Administrative Expenses 575.84 M 539.51 M 533.60 M 457.28 M
Research & Development 61.70 M 50.43 M 48.00 M 35.83 M
Operating Income 54.17 M 111.49 M 123.60 M 139.08 M
Net Income 12.48 M 81.60 M 37.19 M 66.29 M
EPS 0.24 1.60 0.74 1.36
Diluted EPS 0.24 1.48 0.69 1.26
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 292.11 M 274.78 M 288.33 M 271.30 M
Cost Of Revenue 77.58 M 74.49 M 86.13 M 74.16 M
Gross Profit 214.53 M 200.28 M 202.20 M 197.14 M
Selling General & Administrative Expenses 152.85 M 145.08 M 142.20 M 141.21 M
Research & Development 17.55 M 17.58 M 17.09 M 15.25 M
Operating Income 30.20 M 20.17 M 25.86 M 17.97 M
Net Income 14.96 M 9.39 M 12.16 M 15.92 M
EPS 0.29 0.18 0.23 0.31
Diluted EPS 0.29 0.18 0.23 0.30
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 618.21 M 560.06 M 575.44 M 702.83 M
Cash & Cash Equivalents 120.24 M 78.20 M 161.05 M 197.95 M
Total Assets 1.71 B 1.64 B 1.57 B 1.30 B
Total Current Liabilities 179.46 M 161.40 M 242.50 M 99.62 M
Total Liabilities 873.33 M 840.72 M 870.28 M 583.82 M
Shareholder's Equity 834.53 M 795.57 M 694.94 M 711.53 M
Outstanding Stock 51.42 M 50.97 M 50.35 M 49.10 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 664.31 M 606.33 M 618.21 M 579.65 M
Cash & Cash Equivalents 130.77 M 95.79 M 120.24 M 77.51 M
Total Assets 1.81 B 1.75 B 1.71 B 1.68 B
Total Current Liabilities 184.64 M 161.78 M 179.46 M 168.24 M
Total Liabilities 942.59 M 911.10 M 873.33 M 871.78 M
Shareholder's Equity 862.72 M 840.01 M 834.53 M 803.62 M
Outstanding Stock 51.89 M 51.64 M 51.42 M 51.42 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations 219.18 M 176.97 M 158.09 M 88.73 M
Capital Expenditures -101.92 M -110.22 M -88.37 M -75.73 M
Net Cash Flow from Investing Activities -161.29 M -174.86 M -304.89 M -7.51 M
Net Cash Flow from Financial Activities -14.58 M -87.03 M 110.82 M -30.34 M
Free Cash Flow 117.26 M 66.75 M 69.71 M 13.00 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations 68.96 M 176.97 M 158.09 M 88.73 M
Capital Expenditures -31.46 M -33.93 M -23.52 M -25.02 M
Net Cash Flow from Investing Activities -35.56 M -40.76 M -22.64 M -25.49 M
Net Cash Flow from Financial Activities 1.20 M -8.06 M -3.39 M -42.23 M
Free Cash Flow 37.50 M -9.45 M 45.18 M 48.25 M
Key Ratios (Market Close Nov 27, 2020)
Valuation Ratios 2020 2019 2018 2017
P/E Ratio 57.96 60.42 206.50 154.30
Price to Sales Ratio 2.70 2.63 2.31 3.37
Price to Book Ratio 3.05 3.75 4.88 3.73
Enterprise Value to EBIT 66.00 31.00 36.00 20.00
Enterprise Value to EBITDA 17.43 15.13 18.41 13.86
Profitability Ratios 2020 2019 2018 2017
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - 0.70% 5.10%
ROE - - 1.60% 11.00%
Liquidity Ratios 2020 2019 2018 2017
Working Capital 438.75 M 398.67 M 332.95 M 603.21 M
Current Ratio 3.45 3.47 2.37 7.06
Efficiency & Capital Structure Ratios 2020 2019 2018 2017
Debt Equity Ratio 1.09 1.06 1.25 0.82
Asset Turnover Ratio - - 0.66 0.64
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.